Valuation (22%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -41.02 | -20.30 |
| PEG Ratio (TTM) | 0.96 | -5.71 |
| P/S Ratio (TTM) | 168,283.29 | 50.88 |
| P/B Ratio (TTM) | 6.79 | 29.28 |
| P/FCF Ratio (TTM) | -40.96 | -8.95 |
| Price to 5YR AVG Earnings Ratio | N/A | -6.52 |
| Price to 5YR AVG FCF Ratio | N/A | -14.78 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -15.59% | -18.85% |
| ROE (TTM) | -15.78% | 25.35% |
| Net Profit Margin (TTM) | -409,200.94% | -827.80% |
| ROIC 5YR AVG | N/A | -26.10% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -42.72% | -37,298.83% | N/A |
| Revenue | -25.00% | N/A | N/A |
| Net Income | -46.52% | -19,643.41% | N/A |
| Cash Flow | -32.94% | -3,680.83% | N/A |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 25.51 | 6.09 |
| Quick Ratio (TTM) | 25.51 | 5.87 |
| D/E Ratio (TTM) | N/A | 1.00 |
| Interest Coverage (TTM) | N/A | -9.57 |
| Piotroski F-Score | 2 | 4 |
| Altman Z-Score | 87.86 | 13.84 |
| LTL to 5YR AVG FCF | N/A | 0.07 |
| Shares Outstanding Growth 5YR AVG | N/A | 44.11% |